Tubal patency after clinical treatment of unruptured ectopic pregnancy

Tubal patency after clinical treatment of unruptured ectopic pregnancy

Author Elito, J. Google Scholar
Han, K. K. Google Scholar
Camano, L. Google Scholar
Institution Universidade Federal de São Paulo (UNIFESP)
Abstract Objective: To evaluate tubal patency using hysterosalpingography after clinical treatment of tubal pregnancy. Method: of 80 patients who underwent hysterosalpingography after clinical treatment of tubal pregnancy from April 1994 to February 2002, 30 were treated with a single 50 mg/m(2) dose of methotrexate intramuscularly (n=30) and 50 were followed up expectantly. Results: Patency of the ipsilateral tube was 84% after methotrexate treatment and 78% after expectant management. in addition, contralateral tubal. patency was 97% after methotrexate treatment and 92% after expectant management. There were no statistically significant differences between the groups. Conclusion: Findings from this study suggest similar tubal patency rates after methotrexate treatment and expectant management. (c) 2005 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.
Keywords ectopic pregnancy
expectant management
chorionic gonadotropic hormone
Language English
Date 2005-03-01
Published in International Journal of Gynecology & Obstetrics. Clare: Elsevier Sci Ireland Ltd, v. 88, n. 3, p. 309-313, 2005.
ISSN 0020-7292 (Sherpa/Romeo, impact factor)
Publisher Elsevier B.V.
Extent 309-313
Origin http://dx.doi.org/10.1016/j.ijgo.2004.12.018
Access rights Closed access
Type Article
Web of Science ID WOS:000227833700013
URI http://repositorio.unifesp.br/handle/11600/28177

Show full item record


File Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)




My Account